Karpus Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$625K Hold
680
0.02% 206
2025
Q4
$731K Hold
680
0.02% 189
2025
Q3
$519K Hold
680
0.02% 191
2025
Q2
$530K Hold
680
0.02% 185
2025
Q1
$562K Hold
680
0.02% 182
2024
Q4
$525K Hold
680
0.02% 193
2024
Q3
$602K Hold
680
0.02% 197
2024
Q2
$616K Hold
680
0.02% 202
2024
Q1
$529K Hold
680
0.02% 217
2023
Q4
$396K Hold
680
0.01% 230
2023
Q3
$365K Hold
680
0.01% 246
2023
Q2
$319K Hold
680
0.01% 285
2023
Q1
$234K Hold
680
0.01% 351
2022
Q4
$249K Hold
680
0.01% 398
2022
Q3
$220K Hold
680
0.01% 470
2022
Q2
$220K Buy
+680
New +$204K 0.01% 474

Other funds holding LLY

Karpus Investment Management's LLY Position: Q1 2026 in Review

Karpus Investment Management held its Eli Lilly (LLY) position steady in Q1 2026 at 680 shares worth $625K. The position accounts for 0.02% of the portfolio, ranked #206.

Karpus Investment Management first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $731K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Karpus Investment Management held 680 shares of Eli Lilly worth $625K as of Q1 2026.
  • Karpus Investment Management left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.02% of Karpus Investment Management's portfolio in Q1 2026, its #206 holding.
  • Karpus Investment Management first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
  • Karpus Investment Management's Eli Lilly position peaked at $731K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Karpus Investment Management's 13F filing for Q1 2026, filed 14 May 2026.